Literature DB >> 28884249

CDOCKER and λ-dynamics for prospective prediction in D₃R Grand Challenge 2.

Xinqiang Ding1, Ryan L Hayes2, Jonah Z Vilseck2, Murchtricia K Charles1, Charles L Brooks3,4.   

Abstract

The opportunity to prospectively predict ligand bound poses and free energies of binding to the Farnesoid X Receptor in the D3R Grand Challenge 2 provided a useful exercise to evaluate CHARMM based docking (CDOCKER) and [Formula: see text]-dynamics methodologies for use in "real-world" applications in computer aided drug design. In addition to measuring their current performance, several recent methodological developments have been analyzed retrospectively to highlight best procedural practices in future applications. For pose prediction with CDOCKER, when the protein structure used for rigid receptor docking was close to the crystallographic holo structure, reliable poses were obtained. Benzimidazoles, with a known holo receptor structure, were successfully docked with an average RMSD of 0.97 [Formula: see text]. Other non-benzimidazole ligands displayed less accuracy largely because the receptor structures we chose for docking were too different from the experimental holo structures. However, retrospective analysis has shown that when these ligands were re-docked into their holo structures, the average RMSD dropped to 1.18 [Formula: see text] for all ligands. When sulfonamides and spiros were docked with the apo structure, which agrees more with their holo structure than the structures we chose, five out of six ligands were correctly docked. These docking results emphasize the need for flexible receptor docking approaches. For [Formula: see text]-dynamics techniques, including multisite [Formula: see text]-dynamics (MS[Formula: see text]D), reasonable agreement with experiment was observed for the 33 ligands investigated; root mean square errors of 2.08 and 1.67 kcal/mol were obtained for free energy sets 1 and 2, respectively. Retrospectively, soft-core potentials, adaptive landscape flattening, and biasing potential replica exchange (BP-REX) algorithms were critical to model large substituent perturbations with sufficient precision and within restrictive timeframes, such as was required with participation in Grand Challenge 2. These developments, their associated benefits, and proposed procedures for their use in future applications are discussed.

Entities:  

Keywords:  CDOCKER; D3R; Drug design data resources; Free energy calculation; Protein-ligand docking; dynamics

Mesh:

Substances:

Year:  2017        PMID: 28884249      PMCID: PMC5767529          DOI: 10.1007/s10822-017-0050-5

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  41 in total

1.  Practical Aspects of Free-Energy Calculations: A Review.

Authors:  Niels Hansen; Wilfred F van Gunsteren
Journal:  J Chem Theory Comput       Date:  2014-06-06       Impact factor: 6.006

2.  Charge-leveling and proper treatment of long-range electrostatics in all-atom molecular dynamics at constant pH.

Authors:  Jason A Wallace; Jana K Shen
Journal:  J Chem Phys       Date:  2012-11-14       Impact factor: 3.488

Review 3.  Virtual screening strategies in drug discovery: a critical review.

Authors:  A Lavecchia; C Di Giovanni
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

4.  Computer-aided discovery of anti-HIV agents.

Authors:  William L Jorgensen
Journal:  Bioorg Med Chem       Date:  2016-07-21       Impact factor: 3.641

5.  Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges.

Authors:  K Vanommeslaeghe; E Prabhu Raman; A D MacKerell
Journal:  J Chem Inf Model       Date:  2012-11-28       Impact factor: 4.956

6.  Adaptive Landscape Flattening Accelerates Sampling of Alchemical Space in Multisite λ Dynamics.

Authors:  Ryan L Hayes; Kira A Armacost; Jonah Z Vilseck; Charles L Brooks
Journal:  J Phys Chem B       Date:  2017-02-10       Impact factor: 2.991

7.  D3R grand challenge 2015: Evaluation of protein-ligand pose and affinity predictions.

Authors:  Symon Gathiaka; Shuai Liu; Michael Chiu; Huanwang Yang; Jeanne A Stuckey; You Na Kang; Jim Delproposto; Ginger Kubish; James B Dunbar; Heather A Carlson; Stephen K Burley; W Patrick Walters; Rommie E Amaro; Victoria A Feher; Michael K Gilson
Journal:  J Comput Aided Mol Des       Date:  2016-09-30       Impact factor: 3.686

8.  Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles.

Authors:  Robert B Best; Xiao Zhu; Jihyun Shim; Pedro E M Lopes; Jeetain Mittal; Michael Feig; Alexander D Mackerell
Journal:  J Chem Theory Comput       Date:  2012-07-18       Impact factor: 6.006

Review 9.  Overview of the SAMPL5 host-guest challenge: Are we doing better?

Authors:  Jian Yin; Niel M Henriksen; David R Slochower; Michael R Shirts; Michael W Chiu; David L Mobley; Michael K Gilson
Journal:  J Comput Aided Mol Des       Date:  2016-09-22       Impact factor: 3.686

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more
  2 in total

Review 1.  Improving small molecule virtual screening strategies for the next generation of therapeutics.

Authors:  Bentley M Wingert; Carlos J Camacho
Journal:  Curr Opin Chem Biol       Date:  2018-06-17       Impact factor: 8.822

2.  D3R grand challenge 4: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energies.

Authors:  Conor D Parks; Zied Gaieb; Michael Chiu; Huanwang Yang; Chenghua Shao; W Patrick Walters; Johanna M Jansen; Georgia McGaughey; Richard A Lewis; Scott D Bembenek; Michael K Ameriks; Tara Mirzadegan; Stephen K Burley; Rommie E Amaro; Michael K Gilson
Journal:  J Comput Aided Mol Des       Date:  2020-01-23       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.